Recombinant Human ALK-7/Activin RIC Protein,hFc Tag

Scan for product

HEK293细胞表达系统2型糖尿病研究心血管疾病研究心血管重塑研究抗体药物开发

Product no.94082ES Sizes3 options SourceYeasen · Official

Cat. No. 94082ES25

现货 $1,015.00

Qty 1

Enquire now

Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status

94082ES25 25 μg $1,015.00 现货 Enquire

94082ES60 100 μg $4,055.00 现货 Enquire

94082ES76 500 μg $13,505.00 现货 Enquire

Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen

Cat.No94082ES

Specification高活性、高纯度、低内毒素、高批间一致性

Origin翌圣生物科技(上海)股份有限公司

技术平台 HEK293细胞表达系统

应用方法 2型糖尿病研究疾病机制研究 心血管疾病研究疾病机制研究 心血管重塑研究病理机制研究 抗体药物开发靶点蛋白

适用物种种属人

检测方法 十二烷基硫酸钠-聚丙烯酰胺凝胶电泳 体积排阻高效液相色谱 鲎试剂法 酶联免疫吸附测定

生物特性参数 蛋白类型重组蛋白 种属来源人 生物活性描述ELISA Data 1: Immobilized Human ALK-7 hFc Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Anti-ALK-7 Antibody hFc Tag with the EC50 of 4.1ng/ml determined by ELISA. 应用2型糖尿病、心血管疾病研究 表达序列Glu21-Glu113 数据库编号Q8NER5-1 产品别称ACTR-IC;ACVR1C;ALK7;Activin R1C

技术参数纯度> 95% as determined by SDS-PAGE and SEC-HPLC 内毒素水平Less than 1 EU per μg by the LAL method. 分子量The protein has a predicted MW of 35.96 kDa. Due to glycosylation the protein migrates to 48-60 kDa based on Bis-Tris PAGE result. 制剂形式Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. 复溶方法用蒸馏水溶解冻干的蛋白。如果规格为25μg或者100μg，建议复溶到0.5mg/mL的浓度。对于500μg或1mg的冻干粉，建议以1mg/mL的浓度复溶。复溶过程中请不要剧烈涡旋或者剧烈摇晃。将复溶后的蛋白溶液按照需求进行分装，储存于至-80℃，避免反复冻融。 储存条件-25~-15℃保存，收到货之日起，有效期1年。复溶后， -85~-65℃保存，3个月有效期。避免反复冻融。 表达系统HEK293 标签C-hFc 外观Lyophilized Powder